Low-Dose Rivaroxaban Did Not Reduce LV Thrombus After Anterior STEMI

Adding low-dose rivaroxaban to dual antiplatelet therapy following anterior myocardial infarction did not reduce cardiac MRI–detected left ventricular thrombus at 1 month and increased minor bleeding in a 560-patient randomized trial.